Medicare Advantage covers more than half of all Medicare beneficiaries — roughly 33 million people — and 2026 is shaping up to be one of the more consequential years of change the program has seen. Premiums, cost-sharing structures, prior authorization timelines, supplemental benefits, and drug coverage rules are all shifting in ways that can directly affect what you pay and what care you can actually access. If you enrolled in a plan two or three years ago and have not revisited it since, there is a real chance your plan no longer offers the same value it once did.
Start with the premium picture, because it is more complicated than the advertisements suggest. Many Medicare Advantage plans continue to advertise $0 monthly premiums in 2026, and that figure is technically accurate — but it does not tell the whole story. Every Medicare Advantage enrollee still pays the standard Medicare Part B premium, which in 2026 is $185.00 per month for most beneficiaries (higher-income enrollees pay more under IRMAA surcharges, reaching up to $628.90 per month at the top income tier). Beyond Part B, a $0-premium plan shifts costs into its cost-sharing structure: higher copays for specialist visits, steeper coinsurance for hospital stays, and larger deductibles. A plan charging a $25 monthly premium but capping your hospital coinsurance at 20% may cost you far less over a year than a $0-premium plan with a $400-per-day hospital copay for days one through five.
The out-of-pocket maximum is the single most important number to compare when evaluating Medicare Advantage plans, and in 2026 the CMS-set ceiling for in-network services is $9,350. That is the most you should pay in a calendar year for covered in-network care before your plan picks up 100% of costs. For plans that cover out-of-network services — typically PPOs rather than HMOs — the combined in-network and out-of-network limit can reach $14,000 or higher. Critically, the federal ceiling is a cap on what plans are allowed to set, not a standard that every plan adopts. Many plans set their actual limit well below $9,350 — some as low as $3,500 or $4,500 — which is a meaningful protection if you face a hospitalization, cancer treatment, or major orthopedic procedure. The only way to know your plan's actual limit is to read the Evidence of Coverage document, not the Summary of Benefits, which sometimes buries this figure in fine print.
Prior authorization has been the most persistent source of complaints among Medicare Advantage enrollees for years, and 2026 brings the most significant federal intervention to date. Prior authorization is the process by which your insurer must approve certain services, procedures, or medications before you receive them. CMS finalized rules — now being actively enforced in 2026 — that require plans to render decisions on urgent prior authorization requests within 72 hours and on standard requests within 7 calendar days. Plans must also provide specific clinical reasons when they deny a request, ending the practice of issuing vague rejections that gave patients no clear basis for appeal. These timelines apply to both initial requests and reconsiderations at the plan level.
Knowing your appeal rights under these rules is practical, actionable knowledge. If your plan denies a prior authorization request, the first step is the plan's internal appeal, which must be decided within the same 72-hour or 7-day window depending on urgency. If the internal appeal fails, you can request an independent review by a Qualified Independent Contractor — an organization with no financial relationship to your insurer. Beyond that, you can escalate to an administrative law judge if the amount in dispute exceeds $180 (the 2026 threshold), and ultimately to federal district court. At any stage, your physician can request a peer-to-peer review, where your doctor speaks directly with the plan's medical director. Studies of prior authorization appeals consistently show that a substantial share of initial denials are reversed at the peer-to-peer or first formal appeal stage, so do not accept a denial as final without pursuing at least one level of review.
Supplemental benefits — the dental, vision, hearing, fitness, over-the-counter, and transportation extras that Medicare Advantage plans offer beyond Original Medicare — remain available in 2026, but the benefit landscape has contracted noticeably from its peak in 2022 and 2023. Insurers expanded these extras aggressively when CMS payment benchmarks were favorable and competition for enrollees was intense. In 2026, tighter federal payment rates and higher-than-expected medical costs have pushed many plans to trim or restructure these offerings. A plan that provided a $500 annual dental allowance in 2025 may have reduced it to $250 in 2026, or may have narrowed coverage to preventive services only, excluding fillings and extractions. Hearing aid benefits — which can represent $1,500 to $3,000 in value per pair — are particularly variable: some plans cover one pair every two years, others every three, and some have eliminated the benefit entirely for 2026.
Over-the-counter allowances, which some plans offered at $100 to $150 per quarter for items like vitamins, pain relievers, and blood pressure monitors, have also been reduced or restructured by a number of insurers. Fitness benefits like SilverSneakers gym memberships, once nearly universal among Medicare Advantage plans, are now offered by a smaller share of plans in some markets. The practical takeaway is straightforward: do not assume that benefits you used in 2025 are still available at the same level in 2026. Your plan was required to mail you an Annual Notice of Change by September 30, 2025, detailing every modification to benefits and cost-sharing for the current year. If you did not read that document carefully, it is worth pulling up your plan's current Evidence of Coverage on Medicare.gov to verify what you actually have.
The Annual Enrollment Period — October 15 through December 7 each year — is the primary window for comparing and switching Medicare Advantage plans, with any changes taking effect January 1. If you missed that window, the Medicare Advantage Open Enrollment Period runs January 1 through March 31 and allows you to switch from one Medicare Advantage plan to another, or to drop Medicare Advantage and return to Original Medicare with a standalone Part D drug plan. You cannot use the OEP to switch between two standalone Part D plans if you are already in Original Medicare. One critical caution about returning to Original Medicare: in most states, you will face medical underwriting if you then try to purchase a Medigap supplemental policy, meaning insurers can charge you higher premiums or deny coverage based on your health history. If you live in one of the states with a birthday rule — California, Idaho, Illinois, Kentucky, Louisiana, Maine, Maryland, Missouri, Nevada, New Jersey, New York, Oklahoma, or Oregon — you have a 30-day window around your birthday each year to switch Medigap plans without underwriting, which provides more flexibility. In all other states, the decision to leave Medicare Advantage deserves careful financial modeling before you act.
Drug coverage is another area where 2026 brings both good news and important nuance. Most Medicare Advantage plans bundle Part D prescription drug coverage (these are called MA-PD plans), and the Inflation Reduction Act's $2,000 annual out-of-pocket cap on Part D costs — which took full effect in 2025 — continues in 2026. For anyone on expensive specialty medications, this cap is a substantial financial protection that did not exist before 2025. However, the specific drugs covered, their tier placement, and the cost-sharing at each tier vary significantly between plans and can change year to year. A medication placed on Tier 2 (preferred generic) under your current plan might be moved to Tier 3 (non-preferred brand) under a different plan, doubling or tripling your monthly cost. Before switching plans during any enrollment window, enter your specific medications and dosages into the Medicare Plan Finder at Medicare.gov, which calculates estimated annual drug costs across all plans available in your zip code — this tool is free, requires no login, and is updated with current formulary data.
Network adequacy deserves attention that it rarely gets in plan marketing materials. Medicare Advantage HMOs generally require you to use in-network providers for all non-emergency care, while PPOs cover out-of-network providers at higher cost-sharing. In 2026, CMS continues to enforce network adequacy standards requiring plans to maintain sufficient primary care physicians, specialists, and hospitals within defined travel distances — but enforcement is imperfect, and rural beneficiaries in particular may find that network options are thin. Before enrolling in any plan, verify that your current doctors, specialists, and preferred hospital are in-network — and do not rely solely on the plan's online provider directory, which can lag behind actual contracting status by weeks or months. Call your doctor's billing office directly, give them the plan name and contract number, and ask whether they are currently accepting new patients under that specific plan.
The broader financial pressures on Medicare Advantage in 2026 are worth understanding as context. Several major insurers reported significant losses on their Medicare Advantage books of business in 2024 and 2025, driven by higher utilization, increased acuity among enrollees, and CMS payment rate adjustments. In response, some insurers exited certain county markets entirely, leaving beneficiaries with plan discontinuation notices and Special Enrollment Periods to find new coverage. If your plan was discontinued and you did not actively choose a new plan, CMS assigned you to a comparable plan — but that assigned plan may not match your doctors, drug formulary, or benefit preferences. Checking your plan's status each fall, rather than assuming it will auto-renew unchanged, is simply sound practice. The Medicare and You handbook, mailed each fall by CMS, and the Plan Finder at Medicare.gov are the two most reliable tools for making this comparison with current, accurate data.